George Eisenbarth
11Patents
6h-index
15Co-inventors
63Inventor score
Filing activity: Dec 26, 1991 → May 29, 2012
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6703361B2 | Method of treating or preventing Type 1 diabetes by oral administration of insulin | Human Necessities | 54 | Expired |
| US5643868A | Method of treating or preventing type 1 diabetes by oral administration of insulin | Human Necessities | 30 | Expired |
| US5843886A | Method of treating or preventing Type 1 diabetes by oral administration of insulin | Human Necessities | 16 | Expired |
| US5422339A | Peptides having insulin autoantibody but not insulin receptor binding capacity | Chemistry; Metallurgy | 14 | Expired |
| US5891437A | Antigen associated with type I diabetes mellitus | Emerging Cross-Sectional Technologies | 10 | Expired |
| US6930181B1 | Antigen associated with type 1 Diabetes Mellitus | Emerging Cross-Sectional Technologies | 6 | Expired |
| US9629848B2 | Compounds that modulate autoimmunity and methods of using the same | Human Necessities | 5 | Active |
| US5908627A | Antigen associated with Type I diabetes mellitus | Emerging Cross-Sectional Technologies | 4 | Expired |
| US5407802A | Method of accessing the risks of developing type I diabetes | Emerging Cross-Sectional Technologies | 2 | Expired |
| US8673300B2 | Therapeutic compositions and methods for the prevention of autoimmune diseases | Chemistry; Metallurgy | 0 | Active |
| US9939448B2 | Methods for detecting insulin autoantibody | Physics | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.